• 

  August 1, 2025

  Overview of Polycythemia Vera

  Charles H. Weaver, MD

• 

  April 8, 2024

  Treatment of Myelofibrosis

  Charles H. Weaver, MD

• 

  September 3, 2023

  Tips for Confronting Myelofibrosis

  Charles H. Weaver, MD

• 

  September 3, 2023

  Overview of Essential Thrombocythemia

  Charles H. Weaver, MD

• 

  August 30, 2023

  Long Term Survival in Myelofibrosis Improved with Early Use of Jakafi®

  Charles H. Weaver, MD

• 

  August 3, 2022

  Selinexor/Jalafi Combination Shows Early Activity in Myelofibrosis

  Charles H. Weaver, MD

• 

  October 8, 2021

  Graft-versus-Host-Disease (GvHD) in Depth

  Charles H. Weaver, MD

• 

  September 19, 2021

  Jakafi Does Not Increase Risk of New Cancers

  Charles H. Weaver, MD

• 

  May 15, 2021

  Navitoclax for Myelofibrosis

  Charles H. Weaver, MD

• 

  January 28, 2021

  BET Inhibitors Treatment of Myelofibrosis

  Charles H. Weaver, MD

• 

  January 24, 2021

  Imetelstat for Myelofibrosis

  Charles H. Weaver, MD

• 

  January 15, 2021

  Interferon in The Management of PV and ET

  Charles H. Weaver, MD